高原环境诱发大鼠心血管损伤的评估:临床和灌注指标的综合分析
Assessment of Cardiovascular Injury Induced by Plateau Environment in Rats: A Comprehensive Analysis of Clinical and Perfusion Indices
DOI: 10.12677/acm.2024.1441280, PDF,   
作者: 付诗晗, 孙艳秋*:青海大学研究生院,青海 西宁;李敏娟:宁强县中医医院,陕西 汉中
关键词: 高海拔暴露大鼠血液参数心肌灌注脂肪变性High Altitude Exposure Rats Blood Parameters Myocardial Perfusion Steatosis
摘要: 目的:研究高海拔暴露对大鼠血液指标、心肌酶谱、心肌灌注、肺动脉压和免疫组化的影响。方法:平原组(四川成都,海拔约500米) 20只大鼠饲养至4周龄,之后将10只大鼠转移运至青海玛多(海拔4200 m)动物实验室饲养24周。24周后,比较两组大鼠的血液指标、心肌酶谱、心肌灌注、肺动脉压和免疫组化的差异。结果:在血液指标中观察到显著差异,高海拔组RBC、HGB、HCT、MCV、ALT、Cr和TC水平高于平原组(P < 0.05)。此外,AST、LDH和CK在内的心肌酶谱指数在高海拔组显著升高(P < 0.05)。在心肌灌注参数方面,与平原组相比,高海拔组的MBF值较低,而TTP、MTT指标显著增高(P < 0.05)。高海拔组PA水平高于平原组(P < 0.05)。高海拔组大鼠心肌有明显的病理变化,包括心肌细胞排列紊乱、空泡变性。免疫组织化学标记物HIF-2α和VEGF在高海拔组的表达显著高于平原组(P < 0.05)。结论:这项研究表明,暴露在高海拔地区会导致大鼠血液指数、心脏酶谱、心肌灌注、肺动脉压和免疫组织化学的显著变化,并且心肌会受到一定损伤。这些发现表明,高海拔环境会对身体的各个系统产生深远的生理影响。
Abstract: Objective: To study the effects of high altitude exposure on blood indices, cardiac enzyme profile, myocardial perfusion, pulmonary artery pressure and immunohistochemistry in rats. Methods: Twenty rats in the plain group (Chengdu, Sichuan Province, about 500 m above sea level) were reared until 4 weeks of age, after which 10 rats were transferred and transported to the animal laboratory in Mado, Qinghai Province (4200 m above sea level) for 24 weeks. After 24 weeks, the differences in blood indices, cardiac enzyme profiles, myocardial perfusion, pulmonary artery pressure, and immunohistochemistry were compared between the two groups of rats. Results: Significant differences were observed in blood indices, with higher levels of RBC, HGB, HCT, MCV, ALT, Cr and TC in the high altitude group than in the plains group (P < 0.05). In addition, myocardial enzyme profile indices including AST, LDH and CK were significantly higher in the high altitude group (P < 0.05). In terms of myocardial perfusion parameters, MBF values were lower in the high altitude group compared with the plain group, while TTP and MTT indices were significantly higher (P < 0.05). PA levels were higher in the high altitude group than in the plain group (P < 0.05). There were obvious pathological changes in the myocardium of rats in the high altitude group, including disturbed arrangement of cardiomyocytes and vacuolar degeneration. The expression of immunohistochemical markers HIF-2α and VEGF was significantly higher in the high altitude group than in the plains group (P < 0.05). Conclusion: This study demonstrates that exposure to high altitude leads to significant changes in blood indices, cardiac enzyme profiles, myocardial perfusion, pulmonary artery pressure, and immunohistochemistry, and that the myocardium is subjected to some damage in rats. These findings suggest that high altitude environments can have profound physiological effects on various body systems.
文章引用:付诗晗, 孙艳秋, 李敏娟. 高原环境诱发大鼠心血管损伤的评估:临床和灌注指标的综合分析[J]. 临床医学进展, 2024, 14(4): 2181-2190. https://doi.org/10.12677/acm.2024.1441280

参考文献

[1] Li, Y., Zhang, Y. and Zhang, Y. (2018) Research Advances in Pathogenesis and Prophylactic Measures of Acute High Altitude Illness. Respiratory Medicine, 145, 145-152. [Google Scholar] [CrossRef] [PubMed]
[2] Garrido, E., Botella De Maglia, J. and Castillo, O. (2021) Acute, Subacute and Chronic Mountain Sickness. Revista Clínica Española, 221, 481-490. [Google Scholar] [CrossRef] [PubMed]
[3] Burtscher, M., Bachmann, O., Hatzl, T., et al. (2001) Cardiopulmonary and Metabolic Responses in Healthy Elderly Humans during a 1-Week Hiking Programme at High Altitude. European Journal of Applied Physiology, 84, 379-386. [Google Scholar] [CrossRef] [PubMed]
[4] Gudbjartsson, T., Sigurdsson, E., Gottfredsson, M., et al. (2019) [High Altitude Illness and Related Diseases—A Review]. Laeknabladid, 105, 499-507.
[5] Sydykov, A., Mamazhakypov, A., Maripov, A., et al. (2021) Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders. International Journal of Environmental Research and Public Health, 18, Article 1692. [Google Scholar] [CrossRef] [PubMed]
[6] Tashi, Q.Z., Tsering, S.B., Zhou, N.N., et al. (2022) A Study on the Molecular Mechanism of High Altitude Heart Disease in Children. Pharmacogenomics and Personalized Medicine, 15, 721-731. [Google Scholar] [CrossRef
[7] Perger, E., Baillieul, S., Esteve, F., et al. (2022) Nocturnal Hypoxemia, Blood Pressure, Vascular Status and Chronic Mountain Sickness in the Highest City in the World. Annals of Medicine, 54, 1884-1893. [Google Scholar] [CrossRef] [PubMed]
[8] Sitko, S., Cirer-Sastre, R. and López Laval, I. (2019) Effects of High Altitude Mountaineering on Body Composition: A Systematic Review. Nutrición Hospitalaria, 36, 1189-1195. [Google Scholar] [CrossRef] [PubMed]
[9] Mallet, R.T., Burtscher, J., Richalet, J.P., et al. (2021) Impact of High Altitude on Cardiovascular Health: Current Perspectives. Vascular Health and Risk Management, 17, 317-335. [Google Scholar] [CrossRef
[10] Zhang, S., Liu, D., Gesang, D.Z., et al. (2020) Characteristics of Cerebral Stroke in the Tibet Autonomous Region of China. Medical Science Monitor, 26, e919221. [Google Scholar] [CrossRef
[11] Murray, A.J., Montgomery, H.E., Feelisch, M., et al. (2018) Metabolic Adjustment to High-Altitude Hypoxia: From Genetic Signals to Physiological Implications. Biochemical Society Transactions, 46, 599-607. [Google Scholar] [CrossRef
[12] Haase, V.H. (2013) Regulation of Erythropoiesis by Hypoxia-Inducible Factors. Blood Reviews, 27, 41-53. [Google Scholar] [CrossRef] [PubMed]
[13] Villafuerte, F.C., Simonson, T.S., Bermudez, D., et al. (2022) High-Altitude Erythrocytosis: Mechanisms of Adaptive and Maladaptive Responses. Physiology, 37, 175-186. [Google Scholar] [CrossRef] [PubMed]
[14] Senior, J.R. (2012) Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury-Past, Present, and Future. Clinical Pharmacology & Therapeutics, 92, 332-339. [Google Scholar] [CrossRef] [PubMed]
[15] Jeong, S.M., Choi, S., Kim, K., et al. (2018) Effect of Change in Total Cholesterol Levels on Cardiovascular Disease among Young Adults. Journal of the American Heart Association, 7, e008819. [Google Scholar] [CrossRef
[16] Lasisi, T.J., Raji, Y.R. and Salako, B.L. (2016) Salivary Creatinine and Urea Analysis in Patients with Chronic Kidney Disease: A Case Control Study. BMC Nephrology, 17, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[17] Zhu, T., Han, Q., Zhang, X., et al. (2021) Effects of Xinnaoning Combined with Trimetazidine on the Levels of CK and Its Isoenzymes, AST, ALT and LDH in Patients with Myocardial Ischemia. American Journal of Translational Research, 13, 2875-2882.
[18] Naeije, R. (2010) Physiological Adaptation of the Cardiovascular System to High Altitude. Progress in Cardiovascular Diseases, 52, 456-466. [Google Scholar] [CrossRef] [PubMed]
[19] Ge, R.L. and Helun, G. (2001) Current Concept of Chronic Mountain Sickness: Pulmonary Hypertension-Related High-Altitude Heart Disease. Wilderness & Environmental Medicine, 12, 190-194. [Google Scholar] [CrossRef
[20] Sydykov, A., Maripov, A., Muratali Uulu, K., et al. (2019) Pulmonary Vascular Pressure Response to Acute Cold Exposure in Kyrgyz Highlanders. High Altitude Medicine & Biology, 20, 375-382. [Google Scholar] [CrossRef] [PubMed]
[21] Tang, H., Babicheva, A., McDermott, KM., et al. (2018) Endothelial HIF-2α Contributes to Severe Pulmonary Hypertension Due to Endothelial-to-Mesenchymal Transition. American Journal of Physiology-Lung Cellular and Molecular Physiology, 314, L256-L275. [Google Scholar] [CrossRef] [PubMed]
[22] Melincovici, C.S., Boşca, A.B., Şuşman, S., et al. (2018) Vascular Endothelial Growth Factor (VEGF)—Key Factor in Normal and Pathological Angiogenesis. Romanian Journal of Morphology and Embryology, 59, 455-467.